InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,347.20
(
0.43%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.87
(
0.53%
)
Bitcoin
61,375.71
(
-0.38%
)
Post# of 376163
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

OswegoNY

Send PM Follow Ignore
Followers 4
Posts 266
Boards Moderated 0
Alias Born 11/16/2006

OswegoNY

Re: Sulphur Mt. post# 211740

Thursday, 06/25/2009 8:23:43 AM

Thursday, June 25, 2009 8:23:43 AM

Post# of 376163
Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
The results of the trial indicated that IPLEX(TM) did not exhibit a statistically significant improvement in the functional measure of endurance by the six-minute walk test, muscle function, muscle strength, or quality of life in any of the tests utilized in this study. Based on the limited number of subjects enrolled with significant impairments in cognitive function, gastrointestinal function or pain, Insmed was unable to reach any conclusions regarding the effects of IPLEX(TM) on these endpoints

http://finance.yahoo.com/news/Insmed-Announces-Results-of-prnews-21832337.html?x=0&.v=1
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up